(DOX) Amdocs - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: GB0022569080
Stock: Software, Cloud, AI, CRM, Network
Total Rating 44
Risk 95
Buy Signal -0.50
| Risk 5d forecast | |
|---|---|
| Volatility | 22.8% |
| Relative Tail Risk | -2.05% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.87 |
| Alpha | -29.57 |
| Character TTM | |
|---|---|
| Beta | 0.520 |
| Beta Downside | 0.435 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.82% |
| CAGR/Max DD | -0.23 |
EPS (Earnings per Share)
Revenue
Description: DOX Amdocs March 04, 2026
Amdocs Limited (DOX) provides software and services to communication, entertainment, and media service providers globally. The company offers a range of solutions including cloud-based platforms, customer experience suites, and monetization tools. Its offerings encompass areas like customer relationship management (CRM), service orchestration, and digital SIM (eSIM) capabilities. The telecommunications sector is characterized by high capital expenditure and ongoing technological evolution.
Amdocs also provides consulting, network deployment, and managed services, incorporating AI and predictive analytics. These services support various platforms and technologies, ensuring operational efficiency and system integration for its clients. Software-as-a-Service (SaaS) models are prevalent in this industry, offering recurring revenue streams and scalability.
For more detailed analysis of Amdocss financial performance and market position, consider exploring its profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 571.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 3.03 > 1.0 |
| NWC/Revenue: 1.81% < 20% (prev 4.56%; Δ -2.74% < -1%) |
| CFO/TA 0.14 > 3% & CFO 863.7m > Net Income 571.9m |
| Net Debt (704.5m) to EBITDA (950.6m): 0.74 < 3 |
| Current Ratio: 1.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (108.5m) vs 12m ago -4.34% < -2% |
| Gross Margin: 37.60% > 18% (prev 0.36%; Δ 3724 % > 0.5%) |
| Asset Turnover: 72.46% > 50% (prev 77.38%; Δ -4.91% > 0%) |
| Interest Coverage Ratio: 17.35 > 6 (EBITDA TTM 950.6m / Interest Expense TTM 43.3m) |
Altman Z'' 5.81
| A: 0.01 (Total Current Assets 1.54b - Total Current Liabilities 1.46b) / Total Assets 6.34b |
| B: 1.13 (Retained Earnings 7.16b / Total Assets 6.34b) |
| C: 0.12 (EBIT TTM 750.8m / Avg Total Assets 6.32b) |
| D: 1.19 (Book Value of Equity 3.42b / Total Liabilities 2.88b) |
| Altman-Z'' Score: 5.81 = AAA |
Beneish M -3.12
| DSRI: 1.03 (Receivables 962.8m/990.9m, Revenue 4.58b/4.87b) |
| GMI: 0.96 (GM 37.60% / 35.95%) |
| AQI: 1.01 (AQ_t 0.61 / AQ_t-1 0.60) |
| SGI: 0.94 (Revenue 4.58b / 4.87b) |
| TATA: -0.05 (NI 571.9m - CFO 863.7m) / TA 6.34b) |
| Beneish M-Score: -3.12 (Cap -4..+1) = AA |
What is the price of DOX shares?
As of March 04, 2026, the stock is trading at USD 68.65 with a total of 1,672,913 shares traded.
Over the past week, the price has changed by +2.07%, over one month by -7.25%, over three months by -9.06% and over the past year by -18.96%.
Over the past week, the price has changed by +2.07%, over one month by -7.25%, over three months by -9.06% and over the past year by -18.96%.
Is DOX a buy, sell or hold?
Amdocs has received a consensus analysts rating of 4.71.
Therefore, it is recommended to buy DOX.
- StrongBuy: 5
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DOX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 93.8 | 36.7% |
| Analysts Target Price | 93.8 | 36.7% |
DOX Fundamental Data Overview February 28, 2026
P/E Trailing = 13.501
P/E Forward = 9.0827
P/S = 1.6767
P/B = 2.2012
P/EG = 1.0096
Revenue TTM = 4.58b USD
EBIT TTM = 750.8m USD
EBITDA TTM = 950.6m USD
Long Term Debt = 647.1m USD (from longTermDebt, last quarter)
Short Term Debt = 167.8m USD (from shortTermDebt, last quarter)
Debt = 952.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 704.5m USD (from netDebt column, last quarter)
Enterprise Value = 8.38b USD (7.68b + Debt 952.4m - CCE 247.9m)
Interest Coverage Ratio = 17.35 (Ebit TTM 750.8m / Interest Expense TTM 43.3m)
EV/FCF = 11.10x (Enterprise Value 8.38b / FCF TTM 754.9m)
FCF Yield = 9.01% (FCF TTM 754.9m / Enterprise Value 8.38b)
FCF Margin = 16.49% (FCF TTM 754.9m / Revenue TTM 4.58b)
Net Margin = 12.49% (Net Income TTM 571.9m / Revenue TTM 4.58b)
Gross Margin = 37.60% ((Revenue TTM 4.58b - Cost of Revenue TTM 2.86b) / Revenue TTM)
Gross Margin QoQ = 37.04% (prev 37.38%)
Tobins Q-Ratio = 1.32 (Enterprise Value 8.38b / Total Assets 6.34b)
Interest Expense / Debt = 1.18% (Interest Expense 11.3m / Debt 952.4m)
Taxrate = 18.91% (37.0m / 195.4m)
NOPAT = 608.8m (EBIT 750.8m * (1 - 18.91%))
Current Ratio = 1.06 (Total Current Assets 1.54b / Total Current Liabilities 1.46b)
Debt / Equity = 0.28 (Debt 952.4m / totalStockholderEquity, last quarter 3.42b)
Debt / EBITDA = 0.74 (Net Debt 704.5m / EBITDA 950.6m)
Debt / FCF = 0.93 (Net Debt 704.5m / FCF TTM 754.9m)
Total Stockholder Equity = 3.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.05% (Net Income 571.9m / Total Assets 6.34b)
RoE = 16.56% (Net Income TTM 571.9m / Total Stockholder Equity 3.45b)
RoCE = 18.31% (EBIT 750.8m / Capital Employed (Equity 3.45b + L.T.Debt 647.1m))
RoIC = 14.73% (NOPAT 608.8m / Invested Capital 4.13b)
WACC = 7.07% (E(7.68b)/V(8.63b) * Re(7.83%) + D(952.4m)/V(8.63b) * Rd(1.18%) * (1-Tc(0.19)))
Discount Rate = 7.83% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -3.04%
[DCF] Terminal Value 82.39% ; FCFF base≈676.3m ; Y1≈720.2m ; Y5≈864.5m
[DCF] Fair Price = 163.8 (EV 18.39b - Net Debt 704.5m = Equity 17.69b / Shares 107.9m; r=7.07% [WACC]; 5y FCF grow 7.21% → 2.90% )
EPS Correlation: 83.28 | EPS CAGR: 4.40% | SUE: 2.26 | # QB: 1
Revenue Correlation: -19.24 | Revenue CAGR: 0.25% | SUE: 0.40 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.88 | Chg7d=+0.002 | Chg30d=+0.002 | Revisions Net=+1 | Analysts=4
EPS current Year (2026-09-30): EPS=7.46 | Chg7d=+0.002 | Chg30d=+0.013 | Revisions Net=+2 | Growth EPS=+6.7% | Growth Revenue=+3.5%
EPS next Year (2027-09-30): EPS=8.12 | Chg7d=+0.025 | Chg30d=+0.053 | Revisions Net=+3 | Growth EPS=+8.9% | Growth Revenue=+3.6%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.5% (Discount Rate 7.9% - Earnings Yield 7.4%)
[Growth] Growth Spread = +2.2% (Analyst 2.7% - Implied 0.5%)
P/E Forward = 9.0827
P/S = 1.6767
P/B = 2.2012
P/EG = 1.0096
Revenue TTM = 4.58b USD
EBIT TTM = 750.8m USD
EBITDA TTM = 950.6m USD
Long Term Debt = 647.1m USD (from longTermDebt, last quarter)
Short Term Debt = 167.8m USD (from shortTermDebt, last quarter)
Debt = 952.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 704.5m USD (from netDebt column, last quarter)
Enterprise Value = 8.38b USD (7.68b + Debt 952.4m - CCE 247.9m)
Interest Coverage Ratio = 17.35 (Ebit TTM 750.8m / Interest Expense TTM 43.3m)
EV/FCF = 11.10x (Enterprise Value 8.38b / FCF TTM 754.9m)
FCF Yield = 9.01% (FCF TTM 754.9m / Enterprise Value 8.38b)
FCF Margin = 16.49% (FCF TTM 754.9m / Revenue TTM 4.58b)
Net Margin = 12.49% (Net Income TTM 571.9m / Revenue TTM 4.58b)
Gross Margin = 37.60% ((Revenue TTM 4.58b - Cost of Revenue TTM 2.86b) / Revenue TTM)
Gross Margin QoQ = 37.04% (prev 37.38%)
Tobins Q-Ratio = 1.32 (Enterprise Value 8.38b / Total Assets 6.34b)
Interest Expense / Debt = 1.18% (Interest Expense 11.3m / Debt 952.4m)
Taxrate = 18.91% (37.0m / 195.4m)
NOPAT = 608.8m (EBIT 750.8m * (1 - 18.91%))
Current Ratio = 1.06 (Total Current Assets 1.54b / Total Current Liabilities 1.46b)
Debt / Equity = 0.28 (Debt 952.4m / totalStockholderEquity, last quarter 3.42b)
Debt / EBITDA = 0.74 (Net Debt 704.5m / EBITDA 950.6m)
Debt / FCF = 0.93 (Net Debt 704.5m / FCF TTM 754.9m)
Total Stockholder Equity = 3.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.05% (Net Income 571.9m / Total Assets 6.34b)
RoE = 16.56% (Net Income TTM 571.9m / Total Stockholder Equity 3.45b)
RoCE = 18.31% (EBIT 750.8m / Capital Employed (Equity 3.45b + L.T.Debt 647.1m))
RoIC = 14.73% (NOPAT 608.8m / Invested Capital 4.13b)
WACC = 7.07% (E(7.68b)/V(8.63b) * Re(7.83%) + D(952.4m)/V(8.63b) * Rd(1.18%) * (1-Tc(0.19)))
Discount Rate = 7.83% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -3.04%
[DCF] Terminal Value 82.39% ; FCFF base≈676.3m ; Y1≈720.2m ; Y5≈864.5m
[DCF] Fair Price = 163.8 (EV 18.39b - Net Debt 704.5m = Equity 17.69b / Shares 107.9m; r=7.07% [WACC]; 5y FCF grow 7.21% → 2.90% )
EPS Correlation: 83.28 | EPS CAGR: 4.40% | SUE: 2.26 | # QB: 1
Revenue Correlation: -19.24 | Revenue CAGR: 0.25% | SUE: 0.40 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.88 | Chg7d=+0.002 | Chg30d=+0.002 | Revisions Net=+1 | Analysts=4
EPS current Year (2026-09-30): EPS=7.46 | Chg7d=+0.002 | Chg30d=+0.013 | Revisions Net=+2 | Growth EPS=+6.7% | Growth Revenue=+3.5%
EPS next Year (2027-09-30): EPS=8.12 | Chg7d=+0.025 | Chg30d=+0.053 | Revisions Net=+3 | Growth EPS=+8.9% | Growth Revenue=+3.6%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.5% (Discount Rate 7.9% - Earnings Yield 7.4%)
[Growth] Growth Spread = +2.2% (Analyst 2.7% - Implied 0.5%)